Abstract
In the medical field, Alzheimer’s disease (AD), as a neurodegenerative brain disease which is very difficult to diagnose, can cause cognitive impairment and memory decline. Many existing works include a variety of clinical neurological and psychological examinations, especially computer-aided diagnosis (CAD) methods based on electroencephalographic (EEG) recording or MRI images by using machine learning (ML) combined with different preprocessing steps such as hippocampus shape analysis, fusion of embedded features, and so on, where EEG dataset used for AD diagnosis is usually is large and complex, requiring extraction of a series of features like entropy features, spectral feature, etc., and it has seldom been applied in the AD detection based on deep learning (DL), while MRI images were suitable for both ML and DL. In terms of the structural MRI brain images, few differences could be found in brain atrophy among the three situations: AD, mild cognitive impairment (MCI), and Normal Control (NC). On the other hand, DL methods have been used to diagnose AD incorporating MRI images in recent years, but there have not yet been many selective models with very deep layers. In this article, the Gray Matter (GM) Magnetic Resonance Imaging (MRI) is automatically extracted, which could better distinguish among the three types of situations like AD, MCI, and NC, compared with Cerebro Spinal Fluid (CSF) and White Matter (WM). Firstly, FMRIB Software Library (FSL) software is utilized for batch processing to remove the skull, cerebellum and register the heterogeneous images, and the SPM + cat12 tool kits in MATLAB is used to segment MRI images for obtaining the standard GM MRI images. Next, the GM MRI images are trained by some new neural networks. The characteristics of the training process are as follows: (1) The Tresnet, as the network that achieves the best classification effect among several new networks in the experiment, is selected as the basic network. (2) A multi-receptive-field mechanism is integrated into the network, which is inspired by neurons that can dynamically adjust the receptive fields according to different stimuli. (3) The whole network is realized by adding multiple channels to the convolutional layer, and the size of the convolution kernel of each channel can be dynamically adjusted. (4) Transfer learning method is used to train the model for speeding up the learning and optimizing the learning efficiency. Finally, we achieve the accuracies of 86.9% for AD vs. NC, 63.2% for AD vs. MCI vs. NC respectively, which outperform the previous approaches. The results demonstrate the effectiveness of our approach.
Highlights
In 1906, the German psychiatrist Alois Alzheimer introduced a result about the diagnosis of the August Deter disease, which was the embryonic form of Alzheimer’s disease
We test the proposed deep learning framework based on the screening dataset without data leakage, which includes 462 ADNI subjects (85 Alzheimer’s disease (AD), 244 mild cognitive impairment (MCI) and 133 Normal Control (NC) subjects)
On the ADNI dataset without data leakage, the proposed Gray Matter (GM) multireceptive-field classification method achieves an accuracy of 86.9% in AD vs. NC, and 63.2% in AD vs. MCI vs. NC
Summary
In 1906, the German psychiatrist Alois Alzheimer introduced a result about the diagnosis of the August Deter disease, which was the embryonic form of Alzheimer’s disease. After more than 100 years of development, Alzheimer’s disease (AD) has been clearly defined [1,2]. AD is a very common neurodegenerative brain disease characterized by the degeneration of specific nerve cells, presence of neuritic plaques, and neurofibrillary tangles. It causes confusions in memory, cognitive function, and behavior, and the damages are irreversible [3]. The average survival time for AD patients is five years. By 2050, it is expected to rise to 131.5 million patients. Mild cognitive impairment (MCI), which is known as the prodromal stage of AD, is an intermediate process in the conversion of normal people to AD. There are up to 15 percent of people with MCI being converted to AD each year [7,8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.